Assignee
AEROMICS INC
US·16 granted patents·2 pending applications·107 citations·filing 2013–2024
Top patents by PatentIndex Score
18 records- 0197US11801254B2Pharmaceutical compositions and methods of making pharmaceutical compositions comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphateAEROMICS INC·Filed 2020·Granted Oct 31, 2023·5 cites·15 claims
- 0297US11725018B2CrystalsAEROMICS INC·Filed 2021·Granted Aug 15, 2023·4 cites·20 claims
- 0396US10894055B2Pharmaceutical compositions, methods of making pharmaceutical compositions, and kits comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}4-chlorophenyl dihydrogen phosphateAEROMICS INC·Filed 2018·Granted Jan 19, 2021·9 cites·34 claims
- 0495US12091431B2CrystalsAEROMICS INC·Filed 2023·Granted Sep 17, 2024·2 cites·18 claims
- 0595US11873266B2Methods of treating or controlling cytotoxic cerebral edema consequent to an ischemic strokeAEROMICS INC·Filed 2021·Granted Jan 16, 2024·4 cites·25 claims
- 0694US12213987B2Prodrug saltsAEROMICS INC·Filed 2021·Granted Feb 4, 2025·2 cites·10 claims
- 0794US11117909B2CrystalsAEROMICS INC·Filed 2017·Granted Sep 14, 2021·6 cites·30 claims
- 0894US11071744B2Prodrug saltsAEROMICS INC·Filed 2019·Granted Jul 27, 2021·5 cites·20 claims
- 0994US9573885B2Methods of treating cerebral edemaAEROMICS INC·Filed 2015·Granted Feb 21, 2017·20 cites·19 claims
- 1093US11084778B2Methods of treating cardiac edema, neuromyelitis optica, and hyponatremiaAEROMICS INC·Filed 2018·Granted Aug 10, 2021·6 cites·22 claims
- 1192US10258636B2Prodrug saltsAEROMICS INC·Filed 2017·Granted Apr 16, 2019·8 cites·15 claims
- 1292US9827253B2Prodrug saltsAEROMICS INC·Filed 2014·Granted Nov 28, 2017·12 cites·9 claims
- 1391US9949991B2Methods of treating aquaporin-mediated conditionsAEROMICS INC·Filed 2014·Granted Apr 24, 2018·12 cites·17 claims
- 1490US9994514B2Methods of treating cerebral edema and spinal cord edemaAEROMICS INC·Filed 2013·Granted Jun 12, 2018·12 cites·40 claims
- 1589US12496308B2Methods of administering a pharmaceutically acceptable salt of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphateAEROMICS INC·Filed 2023·Granted Dec 16, 2025·0 cites·16 claims
- 1688US12503425B2Methods of treating or controlling cytotoxic cerebral edemaAEROMICS INC·Filed 2023·Granted Dec 23, 2025·0 cites·6 claims
- 1785US2025206765A1CrystalsAEROMICS INC·Filed 2024·Application pending·0 cites
- 1837US2018042873A1Novel methodsAEROMICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AEROMICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →